The Advisory Board (ABCO) to Restructure Health Care Business; Updates Guidance

Go back to The Advisory Board (ABCO) to Restructure Health Care Business; Updates Guidance

Canaccord Genuity Cuts Price Target on The Advisory Board (ABCO) to $36

January 5, 2017 7:55 AM EST

Canaccord Genuity maintained a Buy rating on The Advisory Board Company (NASDAQ: ABCO), and cut the price target to $36.00 (from $45.00), following the company's announced... More